de Mol, C. L. http://orcid.org/0000-0002-3733-1706
Wong, Y. Y. M. http://orcid.org/0000-0002-8828-4487
van Pelt, E. D.
Ketelslegers, I. A.
Bakker, D. P.
Boon, M.
Braun, K. P. J.
van Dijk, K. G. J.
Eikelenboom, M. J.
Engelen, M.
Geleijns, K.
Haaxma, C. A.
Niermeijer, J. M. F.
Niks, E. H.
Peeters, E. A. J.
Peeters-Scholte, C. M. P. C. D.
Poll-The, B. T.
Portier, R. P.
de Rijk-van Andel, J. F.
Samijn, J. P. A.
Schippers, H. M.
Snoeck, I. N.
Stroink, H.
Vermeulen, R. J.
Verrips, A.
Visscher, F.
Vles, J. S. H.
Willemsen, M. A. A. P.
Catsman-Berrevoets, C. E.
Hintzen, R. Q.
Neuteboom, R. F.
Funding for this research was provided by:
Stichting MS Research
Article History
Received: 22 December 2017
Revised: 14 March 2018
Accepted: 15 March 2018
First Online: 22 March 2018
Compliance with ethical standards
:
: C. L. de Mol, Y. Y. M. Wong, E. D. van Pelt, I. A. Ketelslegers, D. P. Bakker, M. Boon, K. P. J. Braun, K. G. J. van Dijk, M. J. Eikelenboom, M. Engelen, K. Geleijns, C. A. Haaxma, J. M. F. Niermeijer, E. H. Niks, E. A. J. Peeters, C. M. P. C. D. Peeters-Scholte, B. T. Poll-The, R. P. Portier, J. F. de Rijk-van Andel, J. P. A. Samijn, H. M. Schippers, I. N. Snoeck, H. Stroink, R. J. Vermeulen, A. Verrips, F. Visscher, J. S. H. Vles, M. A. A. P. Willemsen and C. E. Catsman-Berrevoets report no conflict of interest in respect to this work. R. Q. Hintzen received honoraria for serving on advisory boards for Biogen Idec, Roche, Sanofi. He participated in trials with BiogenIdec, Merck-Serono, Roche, Genzyme and Novartis. R. F. Neuteboom participates in trials with Sanofi Genzyme and Novartis.
: This study was approved by the Medical Ethical Committees of the Erasmus MC in Rotterdam and the other participating centres.